 | • レポートコード：360iR22NB163 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、259ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートでは、2021年に799.49百万ドルであった世界の閉鎖式移送システム市場規模が、2022年に898.87百万ドルになり、2027年まで年平均12.60%で成長して1,630.08百万ドルに達すると予測しています。本レポートでは、閉鎖式移送システムの世界市場を広く調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、種類別（膜間、ニードルレス）分析、閉鎖システム別（クリックロック式システム、カラーツーカラーアライメント式システム、ルアーロック式システム、プッシュターン式システム）分析、装置別（バックアクセス装置、注射器安全装置、バイアルアクセス装置）分析、技術別（空気濾過装置、コンパートメント化装置、ダイヤフラム装置）分析、エンドユーザー別（病院、腫瘍専門クリニック＆腫瘍センター）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などを以下の構成でまとめています。本書では、B. Braun Medical Inc.、Baxter International Inc.、Becton, Dickinson and Company、Caragen Limited、Cardinal Health, Inc.、Carmel Pharma AB、CODAN Medizinische Geräte GmbH & Co. KG、Corvida Medical、Epic Medicalなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の閉鎖式移送システム市場規模：種類別 - 膜間閉鎖式移送システムの市場規模 - ニードルレス閉鎖式移送システムの市場規模 ・世界の閉鎖式移送システム市場規模：閉鎖システム別 - クリックロック式システムの市場規模 - カラーツーカラーアライメント式システムの市場規模 - ルアーロック式システムの市場規模 - プッシュターン式システムの市場規模 ・世界の閉鎖式移送システム市場規模：装置別 - バックアクセス装置の市場規模 - 注射器安全装置の市場規模 - バイアルアクセス装置の市場規模 ・世界の閉鎖式移送システム市場規模：技術別 - 空気濾過装置の市場規模 - コンパートメント化装置の市場規模 - ダイヤフラム装置の市場規模 ・世界の閉鎖式移送システム市場規模：エンドユーザー別 - 病院における市場規模 - 腫瘍専門クリニック＆腫瘍センターにおける市場規模 ・世界の閉鎖式移送システム市場規模：地域別 - 南北アメリカの閉鎖式移送システム市場規模 アメリカの閉鎖式移送システム市場規模 カナダの閉鎖式移送システム市場規模 ブラジルの閉鎖式移送システム市場規模 … - アジア太平洋の閉鎖式移送システム市場規模 日本の閉鎖式移送システム市場規模 中国の閉鎖式移送システム市場規模 インドの閉鎖式移送システム市場規模 韓国の閉鎖式移送システム市場規模 台湾の閉鎖式移送システム市場規模 … - ヨーロッパ/中東/アフリカの閉鎖式移送システム市場規模 イギリスの閉鎖式移送システム市場規模 ドイツの閉鎖式移送システム市場規模 フランスの閉鎖式移送システム市場規模 ロシアの閉鎖式移送システム市場規模 … - その他地域の閉鎖式移送システム市場規模 ・競争状況 ・企業情報 |
The Global Closed System Transfer Devices Market size was estimated at USD 799.49 million in 2021 and expected to reach USD 898.87 million in 2022, and is projected to grow at a CAGR 12.60% to reach USD 1,630.08 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Closed System Transfer Devices to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the market was studied across Membrane to Membrane Systems and Needleless Systems.
Based on Closing Mechanism, the market was studied across Click to Lock Systems, Color to Colour Alignment Systems, Lueker Lock Systems, and Push to Turn systems.
Based on Component, the market was studied across Bag Access Devices, Syringe Safety Devices, and Vial Access Devices.
Based on Technology, the market was studied across Air Filtration Devices, Compartmentalize Devices, and Diaphragm Based Devices.
Based on End-Use, the market was studied across Hospitals and Oncology Clinics & Oncology Centers.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Closed System Transfer Devices market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Closed System Transfer Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Closed System Transfer Devices Market, including B. Braun Medical Inc., Baxter International Inc., Becton, Dickinson and Company, Caragen Limited, Cardinal Health, Inc., Carmel Pharma AB, CODAN Medizinische Geräte GmbH & Co. KG, Corvida Medical, Epic Medical, Equashield LLC, ICU Medical Inc., JMS North America Corporation, Medline Industries LP, Pfizer Inc., REM Systems, Simplivia Healthcare, Terumo Corporation, Teva Pharmaceutical Industries Ltd., Vygon SA, and Yukon Medical, LLC.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Closed System Transfer Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Closed System Transfer Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Closed System Transfer Devices Market?
4. What is the competitive strategic window for opportunities in the Global Closed System Transfer Devices Market?
5. What are the technology trends and regulatory frameworks in the Global Closed System Transfer Devices Market?
6. What is the market share of the leading vendors in the Global Closed System Transfer Devices Market?
7. What modes and strategic moves are considered suitable for entering the Global Closed System Transfer Devices Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Potential demand attributed to rising chronic diseased patients across the globe
5.1.1.2. Proliferation in utilization of cytotoxic and harmful drugs for treatment of numerous diseases
5.1.1.3. Emergence of advancement in closed system transfer devices
5.1.2. Restraints
5.1.2.1. High cost associated with closed system transfer devices manufacturing
5.1.3. Opportunities
5.1.3.1. Ongoing investments with governmental fundings to assist usage of closed system transfer devices
5.1.3.2. Increasing government approvals of cancer treatments with closed system transfer devices
5.1.3.3. Growing numbers of oncology treatment centres along with hospitals for cancer treatments
5.1.4. Challenges
5.1.4.1. Lack of governmental standards coupled with less awareness among the hospital professionals
5.2. Cumulative Impact of COVID-19
6. Closed System Transfer Devices Market, by Type
6.1. Introduction
6.2. Membrane to Membrane Systems
6.3. Needleless Systems
7. Closed System Transfer Devices Market, by Closing Mechanism
7.1. Introduction
7.2. Click to Lock Systems
7.3. Color to Colour Alignment Systems
7.4. Lueker Lock Systems
7.5. Push to Turn systems
8. Closed System Transfer Devices Market, by Component
8.1. Introduction
8.2. Bag Access Devices
8.3. Syringe Safety Devices
8.4. Vial Access Devices
9. Closed System Transfer Devices Market, by Technology
9.1. Introduction
9.2. Air Filtration Devices
9.3. Compartmentalize Devices
9.4. Diaphragm Based Devices
10. Closed System Transfer Devices Market, by End-Use
10.1. Introduction
10.2. Hospitals
10.3. Oncology Clinics & Oncology Centers
11. Americas Closed System Transfer Devices Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Closed System Transfer Devices Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Closed System Transfer Devices Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. B. Braun Medical Inc.
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. Baxter International Inc.
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. Becton, Dickinson and Company
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. Caragen Limited
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. Cardinal Health, Inc.
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. Carmel Pharma AB
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. CODAN Medizinische Geräte GmbH & Co. KG
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. Corvida Medical
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. Epic Medical
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. Equashield LLC
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. ICU Medical Inc.
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. JMS North America Corporation
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. Medline Industries LP
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. Pfizer Inc.
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. REM Systems
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
15.16. Simplivia Healthcare
15.16.1. Business Overview
15.16.2. Key Executives
15.16.3. Product & Services
15.17. Terumo Corporation
15.17.1. Business Overview
15.17.2. Key Executives
15.17.3. Product & Services
15.18. Teva Pharmaceutical Industries Ltd.
15.18.1. Business Overview
15.18.2. Key Executives
15.18.3. Product & Services
15.19. Vygon SA
15.19.1. Business Overview
15.19.2. Key Executives
15.19.3. Product & Services
15.20. Yukon Medical, LLC
15.20.1. Business Overview
15.20.2. Key Executives
15.20.3. Product & Services
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing